Clinical Trials
28 trialsPredicting Disease Progression and/or Recurrence in Cancer
Massachusetts General Hospital
ROTOR
Novartis
Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice
Pfizer
LAANTERN
Monteris Medical
Clinicopathologic Characteristics, Progression, and Prognostic Analysis of IPNB
The First Hospital of Jilin University
Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Line CDK 4/6 Inhibitors and Endocrine Therapy
Ain Shams University
Understanding Communication in Healthcare to Achieve Trust (U-CHAT)
St. Jude Children's Research Hospital
LAASR
Monteris Medical
Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective Registry
Monteris Medical
Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer
Wroclaw Medical University
SLNB After Neoadjuvant Treatment in Node Positive Patients
Clinical Hospital Center Rijeka
DD
University Medical Center Groningen
PATNIC
Norwegian University of Science and Technology
Optimal EGFR TKIs Treatment Strategies for Lung Adenocarcinoma Harboring EGFR Exon 19 Deletion Variants
National Taiwan University Hospital
ELY
Hôpital Cochin
SIS
West China Hospital
Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer
National Institutes of Health Clinical Center (CC)
SPECIFY
University Hospital, Montpellier
Salvage Surgery for Patients With Metastatic GIST With Rego
Chang Gung Memorial Hospital
Tumor Relapsed Study of Serum Trxr Activity in Advanced Non-small Cell Lung Cancer
Hunan Province Tumor Hospital
The Role of Protein Tyrosine Kinase 7 (PTK7) in Non-small Cell Lung Cancer
National Taiwan University Hospital
Study on the Role of FDG-PET in Patients With FL at Time of Relapse/Progression
Fondazione Italiana Linfomi - ETS
Treatment After Progression of Fulvestrant Among Metastatic Breast Cancer Patients
Fudan University
The Roles of Tissue Factor in Malignant Gliomas
Ontario Clinical Oncology Group (OCOG)
p16 and Ki-67 Stainings and Natural Killer (NK) Cells in CIN-II Management
Parc de Salut Mar
Management of Metastatic Breast Cancer in Clinical Practice - Retrospective Study
AstraZeneca
Patient-reported Outcome Questionnaire for Women With Metastatic Breast Cancer
Health Outcomes Solutions
Markers for Breast Cancer
National Institutes of Health Clinical Center (CC)